2024-12-0369173.25 MB422页
2024-12-037437.92 MB233页
2024-12-034119.02 MB175页
2024-12-03594.95 MB149页
2024-12-0310014.58 MB163页
2024-12-0311039.13 MB197页
2024-12-054459.28 MB143页
2024-12-0566156.78 MB189页
2024-12-056062.46 MB174页
2025-04-144485.29 MB396页
2025-04-14536.35 MB73页
2025-04-1571670.4 MB741页
2025-04-1570123.46 MB278页
2025-04-164387.49 MB1280页
2025-04-165968.16 MB447页
2025-04-163847.81 MB250页
The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information, spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage includes: Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dos 2025-04-176132.87 MB324页
2025-04-264823.5 MB400页
2025-05-126592.68 MB305页
2025-05-125178.46 MB216页